首页 | 本学科首页   官方微博 | 高级检索  
     


Pharmacokinetic profile of Optivate® (high‐purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand disease
Authors:R. Shaikh‐Zaidi  A. Lubetsky  A. Inbal  C. Dash
Affiliation:1. Bio Products Laboratory Limited (Ltd), Dagger Lane, Elstree, Hertfordshire, UK;2. Thrombosis and Hemostasis Unit, National Hemophilia Center, Sheba Medical Center, Tel‐Hashomer, Tel‐Aviv, Israel;3. Sackler School of Medicine, Tel‐Aviv University, Tel‐Aviv, Israel;4. Thrombosis and Hemostasis Unit, Rabin Medical Center and Sackler Faculty of Medicine, Tel‐Aviv University, Tel‐Aviv, Israel;5. CD Consultants, St Albans, UK
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号